Emergent BioSolutions Inc. and Biomedical Advanced Research and Development Authority (?BARDA?), an agency under the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (?HHS?) entered into contract modifications (the ?Modifications?) under which the parties mutually agreed to terminate the U.S. Government and Emergent's Center for Innovation in Advanced Development and Manufacturing Contract (the ?CIADM Contract?) to establish a public-private partnership for pandemic preparedness, issued on June 5, 2012, along with all associated task orders, including the task order issued on May 30, 2020 to reserve capacity and expand manufacturing of third-party COVID-19 vaccines and therapeutics at various Emergent sites (the ?Task Order?), in support of the U.S. Government?s efforts to respond to the COVID-19 pandemic.